NCT06162039

Completed

National Landscape of Hemorrhagic Myocardial Infarction in t...

Rohan Dharmakumar Source

Compare

Other study identifiers

Sponsor study identifier

19978b

Study Type

observational

Actual enrollment (reported)

24,181

Locations

1 country

Sites

1

Timeline

Study Start

December 13, 2023

Actual (reported)

Primary Completion

March 15, 2025

Actual (reported)

Study Completion

March 15, 2025

Actual (reported)

Brief Summary

Registry analysis for prevalence of hemorrhagic myocardial infarction in the United States

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 24,181 participants
Study completion date: March 15, 2025
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
November 30, 2023
Actual (reported)
First Posted
December 8, 2023
Actual (reported)
Study Start
December 13, 2023
Actual (reported)
Primary Completion
March 15, 2025
Actual (reported)
Study Completion
March 15, 2025
Actual (reported)

Last Updated: September 8, 2025
Status Verified: September 2025
Last Update Submitted: September 2, 2025

Conditions

Acute Myocardial Infarction

Outcome Measures

Primary Outcomes (1)

Statewise proportion of Hemorrhagic Myocardial Infarction in the United States
Prevalence of Hemorrhagic Myocardial Infarction
10 years

Secondary Outcomes (3)

Statewise proportion of Acute Heart Failure in Hemorrhagic Myocardial Infarction
30 days
Statewise proportion of re-hospitalization in Hemorrhagic Myocardial Infarction
30 days
Statewise proportion of arrhythmia in Hemorrhagic Myocardial Infarction
30 days

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

All STEMI who underwent primary coronary intervention and revascularisation

You may qualify if:

Acute Myocardial Infarction - STEMI Primary PCI Availability of lab parameters and/or CMR

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Rohan Dharmakumar
Otherlead

Study Sites (1)

Medical Imaging Research Institute, Cardiovascular Imaging Research Center

Indianapolis, Indiana, 46202, United States

Study Officials

Keyur P Vora, MD FACC
Indiana University
PRINCIPAL INVESTIGATOR

Enrollment

24,181 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR INVESTIGATOR
PI Title: Executive Director, Medical Imaging Research Institute

Study Record Dates

First Submitted

November 30, 2023

First Posted

December 8, 2023

Study Start

December 13, 2023

Actual (reported)

Arrhythmia Detection After MI

Not ApplicableRecruiting

NCT00215124

A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction

Phase 1/2Completed

NCT01401881

Ischemic Time and Extent of Myocardial Infarction (MI) With Cardiac Magnetic Resonance Imaging (CMRI) in Patients With ST Elevation Myocardial Infarction (STEMI) and Primary Percutaneous Coronary Intervention (PCI) Study

Unknown

NCT06364150

Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction

Phase 3Unknown

NCT05661825

Cardiac Rehabilitation for the Patients With Acute Myocardial Infarction

Completed

NCT05898425

Coronary Collaterals and Post-reperfusion Intramyocardial Hemorrhage

Completed

Primary Completion

March 15, 2025

Actual (reported)

Study Completion

March 15, 2025

Actual (reported)

Last Updated

September 8, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT06162039
Data provider: ClinicalTrials.gov
Source updated: 2025-09-08
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:36:48 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations